Literature DB >> 8790890

Virus characterization and sequence of the fusion protein gene cleavage site of recent Newcastle disease virus field isolates from the southeastern United States and Puerto Rico.

M C Marín1, P Villegas, J D Bennett, B S Seal.   

Abstract

Nine Newcastle disease virus (NDV) isolates obtained from Puerto Rico, Georgia, Alabama, Mississippi, and Texas were analyzed for in vivo pathogenicity, biological properties (hemagglutination of mammalian erythrocytes), and for sequence variation at the amino acid and sense RNA level of the fusion protein cleavage site. Intracerebral pathogenicity index values ranged from 0 to 0.3 and the intravenous pathogenicity index obtained for all isolates was 0. Four isolates hemagglutinated bovine erythrocytes, whereas no hemagglutination was observed using equine erythrocytes. By direct sequencing of reverse transcription polymerase chain reaction products, all the isolates had a predicted fusion cleavage sequence comparable to lentogenic NDV strains. Based on nucleotide sequence, the viruses could be grouped phylogenetically with the B1 vaccine-type virus. However, nucleotide sequences were not 100% similar to the B1 or La Sota NDV strains, indicating that minor genetic heterogeneity occurs among lentogenic field isolates of NDV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790890

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  Pathotyping of Newcastle disease viruses by RT-PCR and restriction enzyme analysis.

Authors:  T Nanthakumar; R S Kataria; A K Tiwari; G Butchaiah; J M Kataria
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates.

Authors:  L Mia Kim; Daniel J King; Phillip E Curry; David L Suarez; David E Swayne; David E Stallknecht; Richard D Slemons; Janice C Pedersen; Dennis A Senne; Kevin Winker; Claudio L Afonso
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Use of a heteroduplex mobility assay to detect differences in the fusion protein cleavage site coding sequence among Newcastle disease virus isolates.

Authors:  A Berinstein; H S Sellers; D J King; B S Seal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Phylogenetic analysis of Newcastle disease virus genotypes isolated in Japan.

Authors:  Masaji Mase; Kunitoshi Imai; Yasuyuki Sanada; Naoko Sanada; Noboru Yuasa; Tadao Imada; Kenji Tsukamoto; Shigeo Yamaguchi
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

5.  Biological Pathotyping of Newcastle Disease Viruses in Sudan 2008-2013.

Authors:  Egbal Sidahmed Abdelrahim Bilal; Iman Mohammed Elnasri; Aymen Mohamed Alhassan; Khalda Abdelaziz Khalifa; Jedddha Ibrahim Elhag; Selma Osman Ahmed
Journal:  J Vet Med       Date:  2014-11-26

6.  Phylogenetic characterization of the fusion genes of the Newcastle disease viruses isolated in Fars province poultry farms during 2009-2011.

Authors:  Mohammad Javad Mehrabanpour; Setareh Khoobyar; Abdollah Rahimian; Mohammad Bagher Nazari; Mohammad Reza Keshtkar
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

7.  Assessment of contemporary genetic diversity and inter-taxa/inter-region exchange of avian paramyxovirus serotype 1 in wild birds sampled in North America.

Authors:  Andrew M Ramey; Iryna V Goraichuk; Joseph T Hicks; Kiril M Dimitrov; Rebecca L Poulson; David E Stallknecht; Justin Bahl; Claudio L Afonso
Journal:  Virol J       Date:  2017-03-03       Impact factor: 4.099

8.  Phylogenetic analysis of Newcastle disease viruses isolated from waterfowl in the upper midwest region of the United States.

Authors:  Naresh Jindal; Yogesh Chander; Ashok K Chockalingam; Martha de Abin; Patrick T Redig; Sagar M Goyal
Journal:  Virol J       Date:  2009-11-05       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.